KRISTY SMOTHERS: Open Payments
NPI 1922086149 · DURANT, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 65 payments from 13 companies in 2025. Trend: 2023 $558 · 2024 $626 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $235 |
| Otsuka America Pharmaceutical, Inc. | 8 | $214 |
| Vanda Pharmaceuticals Inc. | 16 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $153 |
| Lilly USA, LLC | 4 | $121 |
| Supernus Pharmaceuticals, Inc. | 2 | $53 |
| Novo Nordisk Inc | 2 | $39 |
| Amgen Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Seqirus USA Inc | 1 | $28 |
Products named: REXULTI, FANAPT, CAPLYTA, VRAYLAR, QULIPTA, ZEPBOUND, Qelbree, MOUNJARO.
Industry payments across OK — which companies pay providers there.
